AR T878A
|
Prostate Cancer
|
AR T878A
|
Prostate Cancer
|
prednisone + AST-2970 + PCM-075 Sensitive: C3 – Early Trials
|
prednisone + AST-2970 + PCM-075 Sensitive: C3 – Early Trials
|
AR T878A
|
Prostate Cancer
|
AR T878A
|
Prostate Cancer
|
apalutamide Resistant: C3 – Early Trials
|
apalutamide Resistant: C3 – Early Trials
|
AR T878A
|
Prostate Cancer
|
AR T878A
|
Prostate Cancer
|
abiraterone acetate Resistant: C3 – Early Trials
|
abiraterone acetate Resistant: C3 – Early Trials
|
AR T878A
|
Prostate Cancer
|
AR T878A
|
Prostate Cancer
|
ARV-110 Sensitive: C3 – Early Trials
|
ARV-110 Sensitive: C3 – Early Trials
|